Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma
- 1 June 1998
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 21 (6) , 358-364
- https://doi.org/10.1007/bf03350771
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Multiple endocrine neoplasia types 1 and 2Current Opinion in Endocrinology, Diabetes and Obesity, 1997
- Molecular genetics and clinical implications of medullary thyroid carcinoma and mutations of the RET protooncogeneCurrent Opinion in Endocrinology, Diabetes and Obesity, 1996
- Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of theRET proto-oncogeneInternational Journal of Cancer, 1996
- Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinomaClinical Endocrinology, 1996
- Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutationsSurgery, 1995
- Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinomaClinical Endocrinology, 1995
- Clinical Screening as Compared with DNA Analysis in Families with Multiple Endocrine Neoplasia Type 2ANew England Journal of Medicine, 1994
- Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2AAnnals of Surgery, 1994
- Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entityBritish Journal of Surgery, 1986
- Genetic Aspects of Multiple Endocrine NeoplasiaAnnual Review of Medicine, 1984